Encompass Health reports results for fourth quarter 2020 and issues full-year 2021 guidance and longer term growth targets

Go back to Encompass Health reports results for fourth quarter 2020 and issues full-year 2021 guidance and longer term growth targets

Encompass Health Corporation (EHC) Tops Q4 EPS by 8c, Offers Guidance

January 26, 2021 4:22 PM EST

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.93, $0.08 better than the analyst estimate of $0.85. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.21 billion.

GUIDANCE:

Encompass Health Corporation sees FY2021 EPS of $3.31-$3.53, versus the... More